Target intelligence / Profile preview

Acetylcholine Release at Neuromuscular Junction (ACh Release (NMJ))

Target
ACh Release (NMJ)
Molecular classification
Neurotransmission, Synaptic transmission, Exocytosis
01

Overview

Acetylcholine (ACh) release at the neuromuscular junction (NMJ) is a critical process for translating motor neuron signals into muscle contraction. It involves the calcium-dependent exocytosis of ACh from presynaptic vesicles, diffusion across the synaptic cleft, binding to nicotinic acetylcholine receptors (nAChRs) on the muscle fiber, and subsequent depolarization leading to an action potential and muscle contraction. The process is tightly regulated and terminated by acetylcholinesterase. Disruptions can lead to various neuromuscular disorders.

Other names
Acetylcholine exocytosis at NMJACh synaptic transmission at neuromuscular junctionNeuromuscular transmissionMotor neuron ACh release
02

Mechanism of action

Release of acetylcholine into the synaptic cleft, binding to nicotinic acetylcholine receptors on the muscle fiber, leading to depolarization and muscle contraction.

03

Biological functions

Neuromuscular signalingMuscle contraction initiationVoluntary movementSynaptic communication
04

Disease associations

Myasthenia GravisLambert-Eaton SyndromeBotulismOrganophosphate poisoning
05

Safety considerations

Excessive muscle stimulation leading to paralysis (Botulinum toxin)Overstimulation of cholinergic receptors (Organophosphate poisoning)Muscle weakness or paralysis (Myasthenia Gravis, Lambert-Eaton Syndrome)Drug-induced neuromuscular blockade (e.g., Clindamycin)Respiratory failure
06

Interacting drugs

Botulinum toxin

5 more in the full profile.

07

Biomarkers

Antibodies against acetylcholine receptors (Myasthenia Gravis)Presence of Botulinum toxinCholinesterase levels (Organophosphate poisoning)

Beyond the preview

Go deeper on Acetylcholine Release at Neuromuscular Junction (ACh Release (NMJ)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine Release at Neuromuscular Junction (ACh Release (NMJ)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call